Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-07-057343
Filing Date
2007-09-13
Accepted
2007-09-13 16:27:00
Documents
1
Period of Report
2007-09-11

Document Format Files

Seq Description Document Type Size
1 rrd172353.html 4  
1 rrd172353.xml 4 14001
  Complete submission text file 0001181431-07-057343.txt   15747
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Issuer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address (207) 878-2770
Tomsche David Scott (Reporting) CIK: 0001384044 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12934 | Film No.: 071115739